Faster review times could leave drugmakers vulnerable to litigation, while new Trump administration priorities add more ...

The FDA is launching a National Priority Voucher program to accelerate reviews of certain new drug applications. The agency will distribute a limited number of vouchers in the program’s first ...

A new program to boost U.S. drug manufacturing with streamlined processes, regulatory support. Read more here.